FULPHILA 6 mg, solution for injection in a pre-filled syringe syringe, 0.6 ml
Active ingredients: Pegfilgrastim
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionsyringe, 0.6 mlsous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- FULPHILA 6 mg, solution injectable en seringue préremplie
- Pharmaceutical form
- solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 1 seringue(s) préremplie(s) en verre de 0,6 ml avec système automatique de protection de l'aiguille
- Marketing authorisation holder
- BIOSIMILAR COLLABORATIONS IRELAND (IRLANDE)
- Reimbursement according to BDPM
- 100 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 26 Jun 2020
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60457929CIP73016324CIP133400930163245Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PEGFILGRASTIMsolution | 6 mg · une seringue préremplie de 0,6 mL | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.